These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials. Clément K; van den Akker E; Argente J; Bahm A; Chung WK; Connors H; De Waele K; Farooqi IS; Gonneau-Lejeune J; Gordon G; Kohlsdorf K; Poitou C; Puder L; Swain J; Stewart M; Yuan G; Wabitsch M; Kühnen P; Lancet Diabetes Endocrinol; 2020 Dec; 8(12):960-970. PubMed ID: 33137293 [TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin G modulation of the melanocortin 4 receptor signaling in obesity and eating disorders. Lucas N; Legrand R; Bôle-Feysot C; Breton J; Coëffier M; Akkermann K; Järv A; Harro J; Déchelotte P; Fetissov SO Transl Psychiatry; 2019 Feb; 9(1):87. PubMed ID: 30755592 [TBL] [Abstract][Full Text] [Related]
16. Differential Signaling Profiles of MC4R Mutations with Three Different Ligands. Paisdzior S; Dimitriou IM; Schöpe PC; Annibale P; Scheerer P; Krude H; Lohse MJ; Biebermann H; Kühnen P Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059383 [TBL] [Abstract][Full Text] [Related]
17. Insights into the Allosteric Mechanism of Setmelanotide (RM-493) as a Potent and First-in-Class Melanocortin-4 Receptor (MC4R) Agonist To Treat Rare Genetic Disorders of Obesity through an in Silico Approach. Falls BA; Zhang Y ACS Chem Neurosci; 2019 Mar; 10(3):1055-1065. PubMed ID: 30048591 [TBL] [Abstract][Full Text] [Related]
18. Setmelanotide, a Novel, Selective Melanocortin Receptor-4 Agonist Exerts Anti-inflammatory Actions in Astrocytes and Promotes an Anti-inflammatory Macrophage Phenotype. Kamermans A; Verhoeven T; van Het Hof B; Koning JJ; Borghuis L; Witte M; van Horssen J; de Vries HE; Rijnsburger M Front Immunol; 2019; 10():2312. PubMed ID: 31636637 [TBL] [Abstract][Full Text] [Related]
19. An evaluation of setmelanotide injection for chronic weight management in adult and pediatric patients with obesity due to Bardet-Biedl syndrome. Lazareva J; Brady SM; Yanovski JA Expert Opin Pharmacother; 2023 Apr; 24(6):667-674. PubMed ID: 37013719 [TBL] [Abstract][Full Text] [Related]
20. Functional analyses of melanocortin-4 receptor mutations identified from patients with binge eating disorder and nonobese or obese subjects. Tao YX; Segaloff DL J Clin Endocrinol Metab; 2005 Oct; 90(10):5632-8. PubMed ID: 16030156 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]